Pharmagen, Inc. - FORM 10-Q - EX-32.1 - EXHIBIT 32.1 SECTION 906 CERTIFICATION - August 14, 2012

Attached files

file filename
EX-31.2 - EXHIBIT 31.2 SECTION 302 CERTIFICATION - Pharmagen, Inc.f10q063012_ex31z2.htm
EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - Pharmagen, Inc.f10q063012_ex31z1.htm
EX-32.2 - EXHIBIT 32.2 SECTION 906 CERTIFICATION - Pharmagen, Inc.f10q063012_ex32z2.htm
EX-10.20 - SUNPEAKS HURRICANE SPORTS AGREEMENT (00054674).DOCX - Pharmagen, Inc.f10q063012_ex10z20.htm
EX-10.15 - EXHIBIT 10.15 AZ CARDINALS AGREEMENT - Pharmagen, Inc.f10q063012_ex10z15.htm
EX-10.14 - EXHIBIT 10.14 PHILADELPHIA SOUL AGREEMENT - Pharmagen, Inc.f10q063012_ex10z14.htm
EX-10.19 - EXHIBIT 10.19 PULSE ADVERTISING AGREEMENT - Pharmagen, Inc.f10q063012_ex10z19.htm
EX-10.13 - EXHIBIT 10.13 PASS THROUGH AGREEMENT TRAILBLAZER - Pharmagen, Inc.f10q063012_ex10z13.htm
EX-10.16 - EXHIBIT 10.16 BURT REYNOLDS SOVERIGN TALENT AGREE - Pharmagen, Inc.f10q063012_ex10z16.htm
EX-10.11 - EXHIBIT 10.11 PROMISSORY NOTE LYSANDER OVERSEAS - Pharmagen, Inc.f10q063012_ex10z11.htm
EX-10.18 - EXHIBIT 10.18 WFAN CBS RADIO AGREEMENT - Pharmagen, Inc.f10q063012_ex10z18.htm
10-Q - FORM 10-Q QUARTERLY REPORT JUNE 30 2012 - Pharmagen, Inc.f10q063012_10q.htm
EX-10.17 - EXHIBIT 10.17 DAYTON WALGREENS AGREEMENT - Pharmagen, Inc.f10q063012_ex10z17.htm

EXHIBIT 32.1


CERTIFICATION PURSUANT TO 18 USC, SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Sunpeaks Ventures, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2012, as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, Mackie Barch, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:


(1)  

The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)  

Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated:  August 14, 2012

 

 

 

 

/s/ Mackie Barch

 

By:

Mackie Barch

 

 

Chief Executive Officer





A signed original of this written statement required by Section 906 has been provided to Sunpeaks Ventures, Inc. and will be retained by Sunpeaks Ventures, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.




Pharmagen, Inc. Reports